Related references
Note: Only part of the references are listed.A Suggested Approach to Simplify and Improve Cervical Screening in the United States
Mark Schiffman et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2016)
Squamous Cell Carcinoma of the Vulva A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR)
Fei Dong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: A review of the current literature
Marjolijn D. Trietsch et al.
GYNECOLOGIC ONCOLOGY (2015)
Global availability of data on HPV genotype-distribution in cervical, vulvar and vaginal disease and genotype-specific prevalence and incidence of HPV infection in females
Monika Wagner et al.
INFECTIOUS AGENTS AND CANCER (2015)
Genetic and epigenetic variation in vulvar cancer: Current research and future clinical practice
Rebekah E. McWhirter et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2014)
Temsirolimus in Daily Use: Results of a Prospective Multicentre Noninterventional Study of Patients with Metastatic Kidney Cancer
Andres Jan Schrader et al.
EUROPEAN UROLOGY (2014)
CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma
Marjolijn D. Trietsch et al.
GYNECOLOGIC ONCOLOGY (2014)
MEK1/2 inhibitors in the treatment of gynecologic malignancies
Caela R. Miller et al.
GYNECOLOGIC ONCOLOGY (2014)
mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review
Nader Husseinzadeh et al.
GYNECOLOGIC ONCOLOGY (2014)
Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: A population-based case-control study
Clara Bodelon et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Fascin and cyclin D1 immunoreactivity in non-neoplastic vulvar squamous epithelium, vulvar intraepithelial neoplasia and invasive squamous carcinoma: correlation with Ki67 and p16 protein expression
C. J. R. Stewart et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Designing a High-Throughput Somatic Mutation Profiling Panel Specifically for Gynaecological Cancers
Vivian M. Spaans et al.
PLOS ONE (2014)
Cyclin-Dependent Kinase Modulators and Cancer Therapy
Marialucia Gallorini et al.
BIODRUGS (2013)
Etiology of vulvar cancer will impact on treatment options and therapy outcome: Two major pathways of vulvar cancer
Sigrid Regauer et al.
GYNECOLOGIC ONCOLOGY (2013)
Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers
Charles A. Kunos et al.
GYNECOLOGIC ONCOLOGY (2013)
Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma
Marta del Pino et al.
HISTOPATHOLOGY (2013)
Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway
Dana Holzinger et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Biomarkers for Anti-Angiogenic Therapy in Cancer
Markus Wehland et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis
Riccardo Di Fiore et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Emerging drug profile: cyclin-dependent kinase inhibitors
James S. Blachly et al.
LEUKEMIA & LYMPHOMA (2013)
Molecular mechanisms underlying RB protein function
Frederick A. Dick et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Cell cycle-regulatory cyclins and their deregulation in oral cancer
Rajakishore Mishra
ORAL ONCOLOGY (2013)
Improved Clearance during Treatment of HPV-Positive Head and Neck Cancer through mTOR Inhibition
Joseph D. Coppock et al.
NEOPLASIA (2013)
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Mark Wade et al.
NATURE REVIEWS CANCER (2013)
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia
H. J. Mackay et al.
GYNECOLOGIC ONCOLOGY (2012)
Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva
N. S. Horowitz et al.
GYNECOLOGIC ONCOLOGY (2012)
Role of cyclin D1 amplification and expression in vulvar carcinomas
Matthias Choschzick et al.
HUMAN PATHOLOGY (2012)
PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations
Filip Janku et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome
L. Woelber et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside
Beatriz de Melo Maia et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
Isabelle Ray-Coquard et al.
LANCET ONCOLOGY (2012)
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study
Walter H. Gotlieb et al.
LANCET ONCOLOGY (2012)
Global Burden of Human Papillomavirus and Related Diseases
David Forman et al.
VACCINE (2012)
Therapy of Human Papillomavirus-Related Disease
Peter L. Stern et al.
VACCINE (2012)
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors
D. Mahadevan et al.
ANNALS OF ONCOLOGY (2011)
Combining molecular targeted therapies: clinical experience
Xavier Pivot et al.
ANTI-CANCER DRUGS (2011)
Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: a tissue microarray study
Nicolas Samartzis et al.
BMC CANCER (2011)
A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors
Christophe Massard et al.
CELL CYCLE (2011)
Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Renal Cell Carcinoma
Bernard Escudier et al.
DRUGS (2011)
Promising molecular targeted therapies in breast cancer
Radha Munagala et al.
INDIAN JOURNAL OF PHARMACOLOGY (2011)
Association between toll-like receptor expression and human papillomavirus type 16 persistence
Ibrahim I. Daud et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Role of TP53 Mutations in Vulvar Carcinomas
Matthias Choschzick et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2011)
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Human Papillomaviruses As Therapeutic Targets in Human Cancer
Karin Hellner et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: Identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosing
Maria Gabriella Brasca et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Phase I Trial of Pelvic Radiation, Weekly Cisplatin, and 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, NSC # 663249) for Locally Advanced Cervical Cancer
Charles A. Kunos et al.
CLINICAL CANCER RESEARCH (2010)
Differentiated-Type Vulval Intraepithelial Neoplasia Has a High-Risk Association With Vulval Squamous Cell Carcinoma''
Hedwig P. van de Nieuwenhof et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
HPV-related Carcinogenesis: Basic Concepts, Viral Types and Variants
Marcela Lizano et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples
Andrew Conroy et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice
S. Knopp et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
Mandira Ray et al.
ONCOLOGIST (2009)
Decreased survival in EGFR gene amplified vulvar carcinoma
Whitfield B. Growdon et al.
GYNECOLOGIC ONCOLOGY (2008)
Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab
S. D. Richard et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Topical irniquimod can reverse vulvar intraepithelial neoplasia: A randornised, double-blinded study
Ole Mathiesen et al.
GYNECOLOGIC ONCOLOGY (2007)
Epidermal growth factor receptor is involved in the development of an invasive phenotype in Vulvar squamous lesions, but is not related to MIB-1 immunoreactivity
Hermann Brustmann
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Biology of interactions: Antiepidermal growth factor receptor agents
Paul M. Harari et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The role of anglogenesis and COX-2 expression in the evolution of vulvar lichen sclerosus to squamous cell carcinoma of the vulva
Maria Rosaria Raspollini et al.
GYNECOLOGIC ONCOLOGY (2007)
Erlotinib in non-small cell lung cancer treatment: Current status and future development
Cesare Gridelli et al.
ONCOLOGIST (2007)
Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer
Niklas Reimers et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Prevalence of HPV infection among females in the United States
Eileen F. Dunne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder
Xiaoyan Wang et al.
CLINICAL CANCER RESEARCH (2007)
EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil
Im Il Na et al.
EUROPEAN JOURNAL OF CANCER (2007)
MDMX: from bench to bedside
Jean-Christophe W. Marine et al.
JOURNAL OF CELL SCIENCE (2007)
New agents in development for breast cancer
Xiao-ping Gao et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2007)
EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction
M. H. M. Oonk et al.
GYNECOLOGIC ONCOLOGY (2007)
Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva
Alexander Olawaiye et al.
GYNECOLOGIC ONCOLOGY (2007)
Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine
AR Haas et al.
CLINICAL CANCER RESEARCH (2006)
Cyclins D1, D3, E, and A in vulvar carcinoma patients
S Knopp et al.
GYNECOLOGIC ONCOLOGY (2005)
Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-κB-mediated signalling, moderated by TGF-β
MY Yan et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Mechanisms of genomic instability in human cancer:: Insights from studies with human papillomavirus oncoproteins
S Duensing et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma
AP Pinto et al.
GYNECOLOGIC ONCOLOGY (2004)
Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva
M Santos et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia
S Hallez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Mechanisms of human papillomavirus-induced oncogenesis
K Münger et al.
JOURNAL OF VIROLOGY (2004)
Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells
A Psyrri et al.
CANCER RESEARCH (2004)
Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma
AN Rosenthal et al.
BRITISH JOURNAL OF CANCER (2003)
Alterations of the p16 INK4a/Rb/Cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus
E Lerma et al.
HUMAN PATHOLOGY (2002)
Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides
S Zwaveling et al.
JOURNAL OF IMMUNOLOGY (2002)
Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent lesions
KJ Rolfe et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2001)
Share Paper
